BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25468677)

  • 1. Rare uterine cancer: carcinosarcomas. Review from histology to treatment.
    Artioli G; Wabersich J; Ludwig K; Gardiman MP; Borgato L; Garbin F
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):98-104. PubMed ID: 25468677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review literature on uterine carcinosarcoma.
    Singh R
    J Cancer Res Ther; 2014; 10(3):461-8. PubMed ID: 25313723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the management of uterine carcinosarcoma.
    Gurumurthy M; Somoye G; Cairns M; Parkin DE
    Obstet Gynecol Surv; 2011 Nov; 66(11):710-6. PubMed ID: 22186602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of uterine carcinosarcoma: results of 94 patients.
    Gokce ZK; Turan T; Karalok A; Tasci T; Ureyen I; Ozkaya E; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2015 Feb; 25(2):279-87. PubMed ID: 25611900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of Recommended Treatment of Uterine Carcinosarcoma.
    Menczer J
    Curr Treat Options Oncol; 2015 Nov; 16(11):53. PubMed ID: 26374341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma.
    Elshaikh MA; Modh A; Jhingran A; Biagioli MC; Coleman RL; Gaffney DK; Harkenrider MM; Heskett K; Jolly S; Kidd E; Lee LJ; Li L; Portelance L; Sherertz T; Venkatessan AM; Wahl AO; Yashar CM; Small W
    Gynecol Oncol; 2020 Aug; 158(2):460-466. PubMed ID: 32475772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcoma: An overview.
    Pezzicoli G; Moscaritolo F; Silvestris E; Silvestris F; Cormio G; Porta C; D'Oronzo S
    Crit Rev Oncol Hematol; 2021 Jul; 163():103369. PubMed ID: 34051304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
    Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
    Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
    Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
    Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
    Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?
    McCluggage WG
    J Clin Pathol; 2002 May; 55(5):321-5. PubMed ID: 11986333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 12 cases of uterine carcinosarcoma].
    Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L
    Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
    Cicin İ; Özatlı T; Türkmen E; Özturk T; Özçelik M; Çabuk D; Gökdurnalı A; Balvan Ö; Yıldız Y; Şeker M; Özdemir N; Yapar B; Tanrıverdi Ö; Günaydin Y; Menekşe S; Öksüzoğlu B; Aksoy A; Erdogan B; Bekir Hacıoglu M; Arpaci E; Sevinç A
    Balkan Med J; 2016 Sep; 33(5):517-524. PubMed ID: 27761279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
    Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
    Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma.
    Galaal K; Kew FM; Tam KF; Lopes A; Meirovitz M; Naik R; Godfrey KA; Hatem MH; Edmondson RJ
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):88-92. PubMed ID: 19201517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine carcinosarcoma: A review of the literature.
    Cantrell LA; Blank SV; Duska LR
    Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinosarcoma of the uterus in advanced stage: a case report.
    Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
    Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinosarcomas--a retrospective analysis of 21 patients.
    Villena-Heinsen C; Diesing D; Fischer D; Griesinger G; Maas N; Diedrich K; Friedrich M
    Anticancer Res; 2006; 26(6C):4817-23. PubMed ID: 17214346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.